Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 USD | -4.93% | -6.51% | -23.95% |
Financials (USD)
Sales 2024 * | 114M | Sales 2025 * | 4.17M | Capitalization | 157M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -188M | EV / Sales 2024 * | 1.96 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | 68 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-0.92
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | -4.93% | ||
1 week | -6.51% | ||
Current month | -2.25% | ||
1 month | -15.37% | ||
3 months | -35.74% | ||
6 months | -15.67% | ||
Current year | -23.95% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.694 | -4.93% | 972,256 |
24-05-16 | 0.73 | -1.64% | 1,211,387 |
24-05-15 | 0.7422 | +1.28% | 1,988,593 |
24-05-14 | 0.7328 | +1.78% | 2,608,330 |
24-05-13 | 0.72 | -3.00% | 1,362,935 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.95% | 157M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- GOSS Stock